Accessibility Menu
Gb Sciences logo

Gb Sciences

(OTC) GBLX

Current Price$0.00
Market Cap$122.10K
Since IPO (2014)-100%
5 Year-100%
1 Year-25%
1 Month+0%

Gb Sciences Financials at a Glance

Market Cap

$122.10K

Revenue (TTM)

$97.24K

Net Income (TTM)

-$1.04M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.00

Volume

76,611

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.50

Estimated Earnings Date

Sep 1, 2025

GBLX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gb Sciences

Industry

Pharmaceuticals

Employees

2

CEO

Andrea Small-Howard, PhD, MBA

Headquarters

Las Vegas, NV 89118, US

GBLX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

28%

Return on Assets

-13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$122.10K

Shares Outstanding

407.07M

Volume

76.61K

Avg. Volume

44.98K

Financials (TTM)

Gross Profit

-$624.00

Operating Income

-$1.42M

EBITDA

-$1.42M

Operating Cash Flow

-$975.70K

Capital Expenditure

$0.00

Free Cash Flow

-$975.70K

Cash & ST Invst.

$11.99K

Total Debt

$1.76M

Gb Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$97.24K

N/A

Gross Profit

$97.24K

N/A

Gross Margin

100.00%

N/A

Market Cap

$122.10K

N/A

Market Cap/Employee

$61.05K

N/A

Employees

2

N/A

Net Income

-$100.36K

+46.3%

EBITDA

-$66.44K

+55.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$3.02K

-82.7%

Total Debt

$1.99M

+31.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$557.00K

+642.7%

Short Term Debt

$1.44M

+0.0%

Return on Assets

-13.17%

N/A

Return on Invested Capital

28.46%

N/A

Free Cash Flow

-$354.78K

-72.7%

Operating Cash Flow

-$354.78K

-72.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSTCGlobeStar Therapeutics Corporation
$0.00+0.00%
IRBSIR Biosciences Holdings Inc.
$0.00+0.00%
HTDSHard to Treat Diseases Inc.
$0.00+0.00%
MOBOMobile Lads Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
INTCIntel
$124.57+0.07%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%

Questions About GBLX

What is the current price of Gb Sciences?

Gb Sciences is trading at $0.00 per share.

What is the 52-week range for Gb Sciences?

Over the past 52 weeks, Gb Sciences has traded between $0.00 and $0.50.

How much debt does Gb Sciences have?

As of the most recent reporting period, Gb Sciences reported total debt of $1.99M.

How much cash does Gb Sciences have on hand?

Gb Sciences reported $3.02K in cash and cash equivalents in its most recent financial results.

What is Gb Sciences’s dividend yield?

Gb Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.